106 reports of this reaction
3.1% of all BENZALKONIUM CHLORIDE reports
#10 most reported adverse reaction
MUSCULOSKELETAL PAIN is the #10 most commonly reported adverse reaction for BENZALKONIUM CHLORIDE, manufactured by Meijer, Inc.. There are 106 FDA adverse event reports linking BENZALKONIUM CHLORIDE to MUSCULOSKELETAL PAIN. This represents approximately 3.1% of all 3,413 adverse event reports for this drug.
Patients taking BENZALKONIUM CHLORIDE who experience musculoskeletal pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MUSCULOSKELETAL PAIN is moderately reported among BENZALKONIUM CHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to musculoskeletal pain, the following adverse reactions have been reported for BENZALKONIUM CHLORIDE:
The following drugs have also been linked to musculoskeletal pain in FDA adverse event reports:
MUSCULOSKELETAL PAIN has been reported as an adverse event in 106 FDA reports for BENZALKONIUM CHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MUSCULOSKELETAL PAIN accounts for approximately 3.1% of all adverse event reports for BENZALKONIUM CHLORIDE, making it a notable side effect.
If you experience musculoskeletal pain while taking BENZALKONIUM CHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.